Home
News
Interviews
Companies
Videos
Markets
Subscribe
The
Latest
The Latest
News
MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration
News
PsyBio Therapeutics Announces Pre-IND Application Request Has Been Submitted to the United States Food and Drug Administration
News
PharmaDrug's Super Smart Launches Slim MycoWeRx Brand of Functional Mushrooms
News
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
More Articles
FEATURED
MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers
News
Numinus Completes Acquisition of Neurology Centre of Toronto
News
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders
Trending
#
News
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida
#
News
Ketamine One Signs LOI for Two Ketamine Infusion Clinics in Texas
#
News
Ketamine One Signs LOI with Veteran Services USA to Open Therapy Center
#
News
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders
#
News
Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1
Companies
#
Tryp Therapeutics
NEO
NASDAQ
CSE
TSXV
Private Company
#
Cybin Inc.
NEO
NASDAQ
CSE
TSXV
Private Company
#
Field Trip Health
NEO
NASDAQ
CSE
TSXV
Private Company
#
Numinus
NEO
NASDAQ
CSE
TSXV
Private Company
#
Mydecine Innovations Group
NEO
NASDAQ
CSE
TSXV
Private Company
